Designing T-cell engagers: trade-offs between activity and safety
Protein & Cell · 04.06.2026
DOI: 10.1093/procel/pwag038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 04.06.2026. Verfasst von Yue Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems & Innovation Institute for Artificial Intelligence in Medicine, College of Pharmac…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Pioneer and Leading Goose+X” S&T Program of Zhejiang.
Abstract (Originalsprache)
T-cell engagers (TCEs) are an emerging class of immunotherapeutics that have demonstrated considerable clinical efficacy across a range of tumor types. However, their clinical application remains constrained by the challenge of balancing antitumor activity with acceptable safety, which is particularly prominent in solid malignancies. Multiple strategies have been explored to address this trade-off, including molecular engineering, dosing regimens, and patient selection. Nonetheless, within molecular design efforts, activity and toxicity are still largely optimized in isolation. Here, we provide a systematic analysis of the principal TCE design strategies, examining their respective strengths, limitations, and interdependencies. These strategies fall into two broad categories: those centered on the T-cell interface and those directed at the tumor cell. On the T-cell side, we review approaches that enable spatiotemporal control of T-cell activation through anti-CD3 affinity tuning, incorporation of costimulatory signals, and blockade of immunosuppressive pathways. On the tumor side, we discuss the use of antigen selection, binding valency, and tumor microenvironment (TME)-responsive activation as means to enhance tumor-selective cytotoxicity. Although contemporary TCE formats afford increasingly sophisticated, format-driven modulation of function, deeper mechanistic insight into T-cell activation, and TME biology will be essential to develop safer and more effective therapeutics. By integrating and critically comparing existing strategies, this review offers a holistic framework for navigating the activity—safety trade-off and provides guidance for next-generation TCE development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Drug Delivery and Release Systems & Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research & MOE Engineering Research Center of Innovative Anticancer Drugs, Zhejiang University, Hangzhou 310058, China.
- Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 311100, China.
- School of Medicine, Hangzhou City University, Hangzhou 310015, China.
ORCID-Profile: Yue Zhang, Mengmeng Wei, Ying Shen, Zhichao Zhang, Qiaojun He, Bo Yang, Ji Cao, Wenbin Zhao, Wenyi Zhao, Zhan Zhou
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Pioneer and Leading Goose+X” S&T Program of Zhejiang
- Zhejiang Provincial Natural Science Foundation of China
- Fundamental Research Funds for the Central University
- Scientific Research Fund of Zhejiang University
Zitieren
APA
Zhang, Y., Wei, M., Shen, Y., Zhang, Z., He, Q., Yang, B., Cao, J., Zhao, W., Zhao, W., & Zhou, Z. (2026). Designing T-cell engagers: trade-offs between activity and safety. Protein & Cell. https://doi.org/10.1093/procel/pwag038
Vancouver
Zhang Y, Wei M, Shen Y, Zhang Z, He Q, Yang B, et al. Designing T-cell engagers: trade-offs between activity and safety. Protein & Cell. 2026. doi:10.1093/procel/pwag038
BibTeX
@article{Zhang2026,
author = {Zhang, Yue and Wei, Mengmeng and Shen, Ying and Zhang, Zhichao and He, Qiaojun and Yang, Bo and Cao, Ji and Zhao, Wenbin and Zhao, Wenyi and Zhou, Zhan},
title = {Designing T-cell engagers: trade-offs between activity and safety},
journal = {Protein & Cell},
year = {2026},
doi = {10.1093/procel/pwag038}
}
EUVIMED